|
|
|
|
|
|
Tonix Pharm Hldg Cmn (TNXP)
|
|
4.35 +0.03 (+0.69%)
|
5/25/2017 4:00pm
|
|
Open:
|
4.35
|
Pre. Close:
|
4.32
|
|
High:
|
4.35
|
Low:
|
4.25
|
|
Volume:
|
82,700
|
Market Cap:
|
32.56M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
4.38 - 4.71
|
4.71 - 5
|
|
Low:
|
4.02 - 4.14
|
4.14 - 4.24
|
|
Close:
|
4.17 - 4.43
|
4.43 - 4.67
|
|
|
|
|
|
|
Technical analysis (as of: 2017-05-25 4:51:16 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 5.33 One year: 5.84
|
|
Support:
|
Support1: 3.86 Support2: 3.21
|
|
Resistance:
|
Resistance1:
4.56 Resistance2: 5.00
|
|
Pivot:
|
4.15 
|
|
Moving Averages:
|
MA(5): 4.31 MA(20): 4.16
MA(100): 4.79  MA(250): 9.86
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9): -0.04
|
|
%K %D:
|
%K(14,3): 39.77 %D(3): 38.69
|
|
RSI:
|
RSI(14): 54.50
|
|
52-Week:
|
High: 29.50
Low: 3.30 Change(%): -81.0
|
|
Average Vol(K):
|
3-Month: 1040
10-Days 495
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.TNXP has closed below upper band by 12.4%. Bollinger Bands are 56.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to TNXP's normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Thu, 16 Mar 2017 16:52:30 GMT
Tonix Pharmaceuticals Announces 1-for-10 Reverse Stock Split
Fri, 31 Mar 2017 12:56:15 GMT
Tonix Pharmaceuticals: Good And Bad News
Tue, 07 Mar 2017 12:00:52 GMT
Tonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program ...
Thu, 13 Apr 2017 15:22:30 GMT
Tonix Pharmaceuticals Announces Full Exercise and Closing of Underwriters ...
Wed, 29 Mar 2017 10:52:30 GMT
Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD ...
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
